NCT05768711
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05768711
Title Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR) (AVENHIR)
Acronym AVENHIR
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Groupe Francophone des Myelodysplasies
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
CHU d'Amiens Amiens 80054 France Details
CHU d'Angers Angers 49033 France Details
Hôpital Avicenne Bobigny 93009 France Details
Hôpital privé Sévigné Cesson-Sévigné 35510 France Details
CHU de Grenoble Grenoble 38043 France Details
Hôpital Claude Huriez Lille 59037 France Details
CHRU de Limoges Limoges 87046 France Details
Centre Hospitalier de Mont de Marsan Mont-de-Marsan 40000 France Details
CHU de Montpellier - Hôpital Saint Eloi Montpellier 34295 France Details
CHU Hôtel Dieu Nantes 44093 France Details
Hôpital privé du Confluent SAS Nantes 44277 France Details
Hôpital Archet 1 Nice 06200 France Details
Hôpital Saint Louis Paris 75010 France Details
Hôpital Cochin Paris 75014 France Details
CHU de Bordeaux - Hôpital Haut-Lévêque Pessac 33604 France Details
Centre hospitalier Lyon sud Pierre-Bénite 69495 France Details
CHU de Poitiers Poitiers 86021 France Details
Hôpital NOVO Pontoise 95300 France Details
Centre Hospitalier Annecy Genevois - Site d'Annecy Pringy 74374 France Details
Hôpital Pontchaillou Rennes 35033 France Details
Centre Henri Becquerel Rouen 76038 France Details
IUCT oncopole Toulouse 31059 France Details
CHU de Tours - Hôpital Bretonneau Tours 37000 France Details
Institut Gustave Roussy Villejuif 94800 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field